𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Influence of reducing agents on the secretion rate of recombinant erythropoietin from CHO cells

✍ Scribed by Sung Kwan Yoon; Yong-Ho Ahn; In-Chan Kwon; Kyuboem Han; Ji Yong Song

Book ID
110222565
Publisher
Springer Netherlands
Year
1998
Tongue
English
Weight
176 KB
Volume
20
Category
Article
ISSN
0141-5492

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Effects of heat shock on the production
Effects of heat shock on the production of human erythropoietin from recombinant CHO cells
✍ Eric I. Tsao; Martie A. Bohn; Daniel R. Omstead; Michael J. Munster; Vanchai Num πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 707 KB

The production of recombinant proteins by mammalian cells demands a highly controlled environment for cell cultivation. Temperature stress represents a commonly encountered disturbance in both research and process environments. In this study, we examined the effects of heat shock on the expression o

The effect of dissolved oxygen on the pr
The effect of dissolved oxygen on the production and the glycosylation profile of recombinant human erythropoietin produced from CHO cells
✍ Veronica Restelli; Ming-Dong Wang; Norman Huzel; Martin Ethier; Helene Perreault πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 366 KB πŸ‘ 3 views

## Abstract Human recombinant erythropoietin (rHuEPO) was produced from Chinese hamster ovary (CHO) cells transfected with the human EPO gene. The cells were grown in batch cultures in controlled bioreactors in which the set‐points for dissolved oxygen varied between 3% and 200%. The cell‐specific

Identification of the limitations on rec
Identification of the limitations on recombinant gene expression in CHO cell lines with varying luciferase production rates
✍ Emma J. Mead; Lesley M. Chiverton; C. Mark Smales; Tobias von der Haar πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 234 KB πŸ‘ 2 views

## Abstract Mammalian cell lines are currently employed as one of the main cellular factories for the expression of recombinant protein‐based drugs. The establishment of high‐producing cell lines typically begins with a heterogeneous starter population of cells, from which the highest producing cel